Screener
BridgeBio Pharma BBIO Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on trailing twelve months.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's asset turnover?
- BridgeBio Pharma (BBIO) reported asset turnover of 0.5× in Q1 2026.
- How has BridgeBio Pharma's asset turnover changed year-over-year?
- BridgeBio Pharma's asset turnover increased by 249.8% year-over-year, from 0.1× to 0.5×.
- What is the long-term trend for BridgeBio Pharma's asset turnover?
- Over 4 years (2021 to 2025), BridgeBio Pharma's asset turnover has grown at a 60.7% compound annual growth rate (CAGR), from 0.1× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about BridgeBio Pharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude